Abcellera Biologics Inc
F:8QQ
Abcellera Biologics Inc
F:8QQ
Price:
3.194
EUR
9.83%
Market Closed
Market Cap:
€939.2m
Relative Value
The Relative Value of one
8QQ
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 3.194 EUR,
Abcellera Biologics Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
8QQ Relative Value
HIDDEN
Multiples Across Competitors
8QQ Competitors Multiples
Abcellera Biologics Inc Competitors
Abcellera Biologics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Abcellera Biologics Inc
F:8QQ
|
1.1B EUR | 14.5 | -7.4 | -2.8 | -2.6 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 364 | 4 310.7 | 1 366.8 | 2 920.2 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
192.9B USD | 4.3 | 28.8 | 20.1 | 27 | |
| US |
|
Danaher Corp
NYSE:DHR
|
144.8B USD | 5.9 | 40.1 | 20.3 | 29.5 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 15 | 51.6 | 30.3 | 40.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.2B CHF | 5.6 | 38.3 | 28.3 | 28.3 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
262.2B CNY | 5.9 | 17.6 | 17.6 | 17.6 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
34.1B USD | 4.8 | 26.5 | 20.8 | 24.8 | |
| US |
|
Waters Corp
NYSE:WAT
|
31.2B USD | 9.8 | 48.5 | 31.3 | 39.3 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
30B USD | 1.8 | 22.2 | 12.2 | 18.3 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.4B USD | 6.6 | 30.4 | 22.5 | 25 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
